Biocon Biologics collaborates with Yoshindo to commercialize bUstekinumab, bDenosumab in Japan Ruchika Sharma17 Oct 2022 2:30 PM ISTDenosumab, a biosimilar referencing Prolia, is a monoclonal antibody for the treatment of osteoporosis.
Medical Bulletin 20/September/2022 Isra Zaman20 Sept 2022 4:00 PM ISTHere are the top medical news for the day:High intake of whole grains, fiber, fish and omega-3 fatty acids linked to lower risk of death in adults...
Gay men are two times more likely to have inflammatory bowel disease, according to new research Isra Zaman20 Sept 2022 9:00 AM ISTGay men are more than twice as likely to develop inflammatory bowel disease (IBD) than heterosexual men when both populations engage in high-risk...
Intestinal ultrasound detects ulcerative colitis treatment response better than endoscopy: Study Jacinthlyn Sylvia12 Sept 2022 8:00 PM ISTNetherlands: A recent study conducted by Floris de Voogd and his peers found intestinal ultrasound (IUS) to pick up bowel wall thickness (BWT) better...
Tapering steroids by fourth week benefits ulcerative colitis patients: Study Dr. Kamal Kant Kohli30 Aug 2022 8:00 PM ISTJAPAN: Reducing steroid use in ulcerative colitis patients at week 4 may eventually lead to a complete end to treatment, states a study published in...
Intake of fish oil supplements may prevent inflammatory bowel disease, study suggests Medha Baranwal9 Aug 2022 8:00 PM ISTChina: People who frequently take fish oil supplements may be at lower risk for inflammatory bowel diseases (IBDs) and its subtype ulcerative colitis...
Novartis division Sandoz application for proposed biosimilar Hyrimoz's high concentration formulation accepted by EMA Ruchika Sharma19 Jun 2022 11:30 AM ISTUpon approval, the Hyrimoz (100 mg/mL) citrate-free HCF would offer reduced injection volume and potentially decrease the number of injections...
Hyderabad: Ferring Pharma to establish new manufacturing unit for Pentasa Ruchika Sharma26 May 2022 12:45 PM ISTFerring will invest approximately €60M over the next 2-3 years for establishing this manufacturing facility.
Etrasimod Phase 3 trial shows positive results in Ulcerative Colitis patients: Pfizer Ruchika Sharma27 March 2022 9:00 AM ISTNew York: Pfizer Inc. has announced positive topline results from a Phase 3 study of etrasimod, an investigational, oral, once-a-day, selective...
Pediatric-Onset of IBD Increases Cancer Risk in Later Life: JAMA MD Bureau17 March 2022 9:00 AM ISTInflammatory bowel disease is associated with an increased risk of several types of cancer, including colon, small bowel, and upper gastrointestinal...
Sun Pharma gets CDSCO nod for Tofacitinib Roshni Dhar18 Feb 2022 5:32 PM ISTIn a significant development, the Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO) has granted...
Health Bulletin 18/February/2022 Roshni Dhar18 Feb 2022 5:21 PM ISTHere are Top Health stories of the dayHacking: Anti-hijab tweet on doc's account Dr Shantanu R Prabhu, a pediatrician in Ujire, said in a...
